# Progress Status â€” stroke_hc_v8_2

> Updated: 2026-02-18 | ì „ì²´ ë¶„ì„ ì§„í–‰ í˜„í™© ë° ì‹œê°í™” ê²°ê³¼ë¬¼ ì •ë¦¬

---

## ì™„ë£Œëœ ë¶„ì„ (Completed)

### Phase 1: Pre-processing & Integration
- Pipeline (CellBender / Souporcell / Solo / scVI) âœ…
- Clustering (res=2, scvi_snn, 36 clusters) âœ…
- Annotation (anno1: 21 types, anno2: 8 compartments) âœ…
- Annotation QC (doublet/LQ/RBC ì œê±° â†’ 205,277 clean cells) âœ…
- Subset: `5_1_hc_is.qs` (131K), `5_2_is_g3.qs` (54K) âœ…

### Phase 2: Differential Abundance (MASC)
- anno2 Ã— cohort (HC vs Stroke) âœ…
- anno1 Ã— cohort âœ…
- anno2 Ã— g3 (IS only) âœ…
- anno1 Ã— g3 âœ…
- anno2 Ã— cohort (no GEM) âœ…
- anno1 Ã— cohort (no GEM) âœ…

### Phase 3: DEG (Consensus & NEBULA)
- **L1 DEG Consensus**: muscat-edgeR + muscat-DESeq2 + NEBULA (3 methods) âœ…
  - 15/20 clusters with consensus (5 skipped: insufficient methods)
- **L2 DEG**: NEBULA only (203K results) âœ… â€” muscat too sparse for g3
- **Cross-layer concordance**: 134 genes significant in both L1 and L2 âœ…
- **Pathway enrichment** (FGS genes): HALLMARK, KEGG, GOBP âœ…
- **FGS Ã— DEG overlap**: 218/241 FGS genes significant in L1 DEG âœ…

### Phase 4: CCI (Cell-Cell Interaction)

> ìƒì„¸ ë¬¸ì„œ: [`docs/claude/cci/CCI_ANALYSIS_REPORT.md`](cci/CCI_ANALYSIS_REPORT.md)

#### CellChat v1 (Method 2A: sample-wise merged â€” original)
- L1 (HC vs Stroke, anno2): 56 samples âœ…
- L2 (g3, anno2): 32 samples âœ…
- Comparison plots + pathway plots ìƒì„±ë¨, ë‹¨ **rankNet/bubble ë¯¸ìƒì„±** (merged @data ë¹”)

#### CellChat v2 (condition-level from Seurat â€” ì¬êµ¬í˜„) âœ…
- **Seuratì—ì„œ conditionë³„ ì§ì ‘ CellChat ìƒì„±** â†’ @data ì •ìƒ, ëª¨ë“  ë¹„êµ í•¨ìˆ˜ ì‘ë™
- **rankNet (information flow)**: L1 + L2 ëª¨ë‘ ì„±ê³µ âœ… â€” í•µì‹¬ ì‹ ê·œ ê²°ê³¼
  - L1: HC-dominant (TGFb, IL2, IL16) vs Stroke-dominant (RESISTIN, MIF, BAFF)
  - L2: Bad-dominant for nearly all pathways (IL1, RESISTIN, FLT3, MIF)
- **Bubble comparison**: L-R pairë³„ ì¡°ê±´ ë¹„êµ âœ…
- **Diff circles/heatmaps**: netVisual_diffInteraction + netVisual_heatmap âœ…
- **Signaling role heatmaps** (10-11): per-condition outgoing/incoming centrality âœ…
- **Signaling scatter** (12): per-celltype signaling changes between conditions âœ…
- **Signaling role scatter** (13): outgoing vs incoming per celltype âœ…
- **Pathway chord + contribution**: 9 common pathways Ã— 2 conditions = 36 PNG per layer âœ…
- **L1**: 16 main + 36 pathway + 7 scatter = **59 PNG**
- **L2**: 18 main + 36 pathway + 5 scatter = **59 PNG**
- Output: `cci/plots/cellchat_L1_cohort_v2/`, `cellchat_L2_g3_v2/`
- Scripts: `scripts/reimplement_cellchat_v2.R`, `scripts/fix_cellchat_v2_final.R`, `scripts/fix_cellchat_heatmaps.R`

#### MNN (MultiNicheNet) â€” ê·¼ë³¸ì  í•œê³„ í™•ì¸
- anno2 + anno1 ìˆ˜ì¤€ ëª¨ë‘ ì‹¤í–‰ âœ…, **permissive thresholdsë¡œë„ ì¬ì‹¤í–‰** âœ…
- **`group_prioritization_tbl` = 0 rows** (ëª¨ë“  ì„¤ì •ì—ì„œ)
  - ê·¼ë³¸ ì›ì¸: `lr_target_prior_cor` stepì—ì„œ cell typeë‹¹ sample â‰¥5 ë¶ˆì¶©ì¡±
  - multinichenetr íŒ¨í‚¤ì§€ê°€ ì´ ë°ì´í„°ì™€ **ê·¼ë³¸ì ìœ¼ë¡œ ë¹„í˜¸í™˜**
- Intermediate tables í™œìš© ê°€ëŠ¥: DE genes (78K L1), ligand activities (1.2M L1)
- **MNN anno1 ì‹œê°í™”** (intermediates ê¸°ë°˜): L1 6 PNG + 1 PDF, L2 6 PNG + 1 PDF âœ…
- **í–¥í›„**: LIANA (multi-method CCI consensus) ëŒ€ì²´ ê²€í† 

### Phase 5: FGS (Feature Gene Signature)

#### Whole-dataset FGS (n=50)
- 10 methods: 9/10 succeeded (nmf_loadings FAIL) âœ…
- **Ranger best**: AUC 0.713 (xgboost 0.591, elastic_net 0.552)
- **TML**: Ranger ROC 0.869, xgbTree 0.863, GLM 0.804 âœ…
- **CMGI**: 241 genes, top: MT-CO1 (-9.21), RPS26 (+6.58), HLA-DQA2 (-6.52), IFI44L (+5.84) âœ…
- **ì‹œê°í™”**: 8 plots âœ…

#### FGS sweep
- n=100: ì™„ë£Œ âœ…
- n=200: ì§„í–‰ ì¤‘ ğŸ”„

### Phase 6: Trajectory

#### Trajectory v2 (Slingshot + Monocle3)
- scVI UMAP, 3 compartments: Mono (72K), CD4 (51K), CD8 (35K) âœ…

| | Monocyte | CD4+ T | CD8+ T |
|---|---------|--------|--------|
| Pseudotime | 0â€“2.69 | 0â€“2.06 | 0â€“3.34 |
| Lineages | 5 | 6 | 6 |
| Cohort p | <2e-16 | <2e-16 | 5.16e-13 |
| **g3 p** | **<2e-16** | **0.028** | **0.749 (NS)** |

- Gene dynamics v1 (GAM, no batch correction): 36 genes Ã— 3 compartments âœ…
- Gene dynamics v2 (GAMM with batch correction): `analyze_gene_dynamics_v2()` êµ¬í˜„ ì™„ë£Œ âœ…

#### Gene Dynamics v3 (Batch-corrected GAMM) âœ…
- **ì „ì²´ ì™„ë£Œ**: 3 compartments Ã— 2 conditions (cohort, g3) = 6 runs
- Model: `expr ~ s(pt) + cond + s(pt, by=cond) + offset(log(nCount)) + pct.mt + s(GEM, bs="re")`
- ê° run: 36 genes â†’ 36 PNG + summary CSV
- Output: `results/trajectory_v3/{mono,cd4,cd8}/gene_dynamics_{cohort,g3}/`

### Phase 7: Descriptive Figures
- 63 files (UMAP, DotPlot, bars, frequency, heatmaps, pseudotime, FGS) âœ…

### Phase 8: Compositional Analysis

#### scCODA (Bayesian Compositional) âœ…
- **L1 (HC vs Stroke)**: 14/21 cell types credible effect
  - Credible (composition significantly different): CD14+ Mono, CD16+ Mono, CD4+ T, CD4_S100A8_CSF3R, CD8+ T, CD8+ Trm, ISG+ Myeloid, ISG+ T_cell, MAIT, NK_cell, Treg, cDC2, Platelet/PLA, pDC
  - Not credible: B_cell, CD4_S100A8_CD14, Inflammatory Mono, Plasma_cell, Proliferating, cDC1, Mast_cell
  - Fallback (Mann-Whitney): Platelet/PLA most significant (p=9.7e-12, FC=14.2), MAIT (p=1.1e-10, FC=6.1)
- **L2 (g3 Good vs Bad)**: Only **CD14+ Mono** credible effect
  - All other cell types: not credible (FDR=1.0)
  - Fallback: No cell type significant after FDR correction
- **Interpretation**: L1 composition changes robust; L2 composition differences minimal (g3 effect is expression-level, not composition)
- Output: `results/sccoda/`

---

## ì§„í–‰ ì¤‘ (In Progress)

| ë¶„ì„ | ìƒíƒœ | ì„¸ë¶€ | ë¹„ê³  |
|------|------|------|------|
| FGS n=200 sweep | ğŸ”„ ì‹¤í–‰ ì¤‘ | Background | ìë™ ì§„í–‰ |
| Within-cell-type FGS/TML | ğŸ”„ ë¶€ë¶„ ì™„ë£Œ | CD4 T ì™„ë£Œ | 15 cell type subsets ì¤€ë¹„ë¨, ë‚˜ë¨¸ì§€ ì‹¤í–‰ í•„ìš” |
| cNMF | ğŸ”„ K selection ì™„ë£Œ | 3 cell types | CD4 T, Inflam Mono: k_selection done (311 files), NK: factorizing (230 files) |
| MASC anno1 Ã— project_name | ğŸ”„ ì‹¤í–‰ ì¤‘ | Low priority | |

### cNMF Status Detail

| Cell Type | Prepare | Factorize | K Selection | Consensus |
|-----------|---------|-----------|-------------|-----------|
| CD4+ T_Naive/Memory | âœ… | âœ… (311 runs) | âœ… (plot generated) | Pending |
| Inflammatory Monocyte | âœ… | âœ… (311 runs) | âœ… (plot generated) | Pending |
| NK_cell | âœ… | ğŸ”„ (230/311 runs) | Pending | Pending |

### Within-Cell-Type FGS Status

| Cell Type | Subset | FGS | TML | CMGI |
|-----------|--------|-----|-----|------|
| CD4+ T_Naive/Memory | âœ… | âœ… | âœ… | âœ… |
| CD14+ Monocyte | âœ… | Pending | | |
| CD16+ Monocyte | âœ… | Pending | | |
| Inflammatory Monocyte | âœ… | Pending | | |
| CD8+ T_Cytotoxic | âœ… | Pending | | |
| NK_cell | âœ… | Pending | | |
| B_cell | âœ… | Pending | | |
| ISG+ Myeloid | âœ… | Pending | | |
| CD4_S100A8_CD14 | âœ… | Pending | | |
| CD4_S100A8_CSF3R | âœ… | Pending | | |
| CD8+ Trm | âœ… | Pending | | |
| cDC2 | âœ… | Pending | | |
| MAIT | âœ… | Pending | | |
| Plasma_cell | âœ… | Pending | | |
| Treg | âœ… | Pending | | |

---

## ë³´ë¥˜ / ê³„íš (Pending)

| ë¶„ì„ | ìš°ì„ ìˆœìœ„ | ë¹„ê³  |
|------|---------|------|
| MILO v2 (DA testing) | Medium | PCA fix í•„ìš” (scVIâ†’PCA mapping) |
| MNN permissive thresholds | Medium | group_prioritization empty â†’ ë” ê´€ëŒ€í•œ filter ì¬ì‹¤í–‰ |
| CCI Ã— DEG cross-reference | High | MNN DE genesì™€ DEG Consensus/NEBULA êµì°¨ ë¹„êµ |
| Subclustering (Mono, CD4, CD8) | Medium | anno1 ì„¸ë¶„í™” |
| MELD (predicted likelihood) | Low | Per-cell condition density estimation |
| Augur (cell type prioritization) | Low | Expression-based discriminability |
| MOFA+ (multi-omics factor) | Low | Patient-level latent factors |
| scANVI (reference mapping) | Low | ì¶”ê°€ ë¶„ì„ |
| External validation | Low | ì™¸ë¶€ ë°ì´í„°ì…‹ ê²€ì¦ (GSE16561, GSE140275 ë“±) |
| propeller / DirichletReg | Low | Additional compositional methods |

---

## ì‹œê°í™” ê²°ê³¼ë¬¼ ìœ„ì¹˜

ëª¨ë“  ê²°ê³¼ë¬¼ì€ `results/` symlink â†’ `/data/user3/sobj/stroke_hc_v8_2`

### CCI Plots
```
results/cci/plots/
â”œâ”€â”€ cellchat_L1_cohort/          # 49 files (16 comparison + 33 pathway)
â”‚   â”œâ”€â”€ 01-08_comparison_plots   # Circle, heatmap, boxplot (PNG + PDF)
â”‚   â”œâ”€â”€ 11-12_bubble_*.png       # L-R bubble plots (merged)
â”‚   â””â”€â”€ pathways/                # pathway circle + contribution plots
â”œâ”€â”€ cellchat_L2_g3/              # 53 files (16 comparison + 37 pathway)
â”‚   â””â”€â”€ (same structure)
â”œâ”€â”€ mnn_L1_cohort_anno1/         # 6 PNG + 1 PDF + CSVs
â”‚   â”œâ”€â”€ 01_de_summary_bar.png
â”‚   â”œâ”€â”€ 02_volcano_grid.png
â”‚   â”œâ”€â”€ 03_ligand_activity_grid.png
â”‚   â”œâ”€â”€ 04_top_ligand_receiver.png
â”‚   â”œâ”€â”€ 05_circos_ligand_receiver.{pdf,png}
â”‚   â””â”€â”€ 06_ligand_receiver_heatmap.png
â”œâ”€â”€ mnn_L1_cohort_anno2/         # 11 files
â”œâ”€â”€ mnn_L2_g3_anno1/             # 6 PNG + 1 PDF + CSVs
â””â”€â”€ mnn_L2_g3_anno2/
```

### FGS Plots
```
results/fgs/plots/               # 8 PNG
â”œâ”€â”€ 01_method_auc_comparison.png
â”œâ”€â”€ 02_tml_model_comparison.png
â”œâ”€â”€ 03_tml_all_metrics.png
â”œâ”€â”€ 04_signature_importance.png
â”œâ”€â”€ 05_cmgi_top_genes.png
â”œâ”€â”€ 06_cmgi_gene_method_heatmap.png
â”œâ”€â”€ 07_meta_score_distribution.png
â””â”€â”€ 08_meta_score_by_celltype.png
```

### Trajectory Plots
```
results/trajectory_v2/           # 117 PNG (v2: GAM, no batch correction)
â”œâ”€â”€ mono/
â”‚   â”œâ”€â”€ trajectory_overview_scvi.png
â”‚   â”œâ”€â”€ pseudotime_comparison.png
â”‚   â”œâ”€â”€ pseudotime_by_celltype.png
â”‚   â””â”€â”€ gene_dynamics/           # 36 GAM plots
â”œâ”€â”€ cd4/
â””â”€â”€ cd8/

results/trajectory_v3/           # 216 PNG (v3: batch-corrected GAMM)
â”œâ”€â”€ mono/
â”‚   â”œâ”€â”€ gene_dynamics_cohort/    # 36 PNG + summary CSV
â”‚   â””â”€â”€ gene_dynamics_g3/        # 36 PNG + summary CSV
â”œâ”€â”€ cd4/
â”‚   â”œâ”€â”€ gene_dynamics_cohort/
â”‚   â””â”€â”€ gene_dynamics_g3/
â””â”€â”€ cd8/
    â”œâ”€â”€ gene_dynamics_cohort/
    â””â”€â”€ gene_dynamics_g3/
```

### scCODA
```
results/sccoda/
â”œâ”€â”€ l1_composition.csv           # Patient Ã— cell type count matrix (L1)
â”œâ”€â”€ l2_composition.csv           # Patient Ã— cell type count matrix (L2)
â”œâ”€â”€ sccoda_L1_cohort_credible.csv  # Bayesian credible effects (14/21 TRUE)
â”œâ”€â”€ sccoda_L1_cohort_fallback.csv  # Mann-Whitney fallback with FDR
â”œâ”€â”€ sccoda_L2_g3_credible.csv      # Bayesian credible effects (1/21 TRUE)
â””â”€â”€ sccoda_L2_g3_fallback.csv      # Mann-Whitney fallback with FDR
```

### cNMF
```
results/cnmf/
â”œâ”€â”€ CD4plus_T_Naive_Memory/
â”‚   â”œâ”€â”€ CD4plus_T_Naive_Memory.h5ad
â”‚   â””â”€â”€ CD4plus_T_Naive_Memory/
â”‚       â”œâ”€â”€ CD4plus_T_Naive_Memory.k_selection.png
â”‚       â””â”€â”€ cnmf_tmp/             # 311 factorization runs
â”œâ”€â”€ Inflammatory_Monocyte/        # same structure
â””â”€â”€ NK_cell/                      # factorization in progress
```

---

## í•µì‹¬ ë°œê²¬ ìš”ì•½

1. **SIIS (Stroke-Induced Immunosuppression)**: HC ëŒ€ë¹„ Strokeì—ì„œ CCI -37%, DC hub ë¶•ê´´, cDC1 594 DE genes
2. **SIIS = Selective immunosuppression** (rankNet ì‹ ê·œ ë°œê²¬): ì „ì²´ CCI ê°ì†Œí•˜ë‚˜ RESISTIN/MIF/CypAëŠ” Strokeì—ì„œ ì¦ê°€ â†’ ì„ íƒì  ë©´ì—­ì–µì œ + ì—¼ì¦ í™œì„±í™” ë³‘ì¡´
3. **g3 Bad outcome**: ê±°ì˜ ëª¨ë“  CCI pathway ì¦ê°€ (IL1 Bad-only, RESISTIN Bad>>Good) â†’ maladaptive broad immune activation
4. **Trajectory**: g3 effectëŠ” Monoì—ì„œ ìµœê°• (p<2e-16), CD4 ì•½í•¨ (0.028), CD8 ì—†ìŒ (0.749)
5. **FGS meta-genes**: MT-CO1, HLA-DQA2 (DOWN in Bad), RPS26, IFI44L (UP in Bad)
6. **scCODA**: L1 14/21 cell types compositionally different; L2 only CD14+ Mono â†’ g3 effectëŠ” compositionì´ ì•„ë‹Œ expression level
7. **Gene dynamics v3**: 3 compartments Ã— 2 conditions, batch-corrected GAMM ì „ì²´ ì™„ë£Œ

---

## docs/claude/ ë¬¸ì„œ ëª©ë¡

| # | íŒŒì¼ | ë‚´ìš© | ì‘ì„±ì¼ |
|---|------|------|--------|
| 1 | `1_STROKE_HC_V8_2_CONTEXT.md` | ì „ì²´ ë¶„ì„ ì»¨í…ìŠ¤íŠ¸, ë°ì´í„°, íŒŒì´í”„ë¼ì¸ | 2026-02-13 |
| 2 | `2_gene_dynamics_approaches.md` | GAMM ëª¨ë¸ ì„¤ê³„, two-stage pseudobulk ê³„íš | 2026-02-13 |
| 3 | `3_REFACTORING_PLAN.md` | ì½”ë“œë² ì´ìŠ¤ ë¦¬íŒ©í† ë§ ê³„íš | 2026-02-14 |
| 4 | `4_PROJECT_GOALS.md` | ë…¼ë¬¸ êµ¬ì„± ë¶„ì„ 11ê°œ í•­ëª©, ì˜ì¡´ì„±, ìš°ì„ ìˆœìœ„ | 2026-02-16 |
| 5 | `5_ANALYSIS_REPORT.md` | MASC, DEG, frequency ë“± ë¶„ì„ ê²°ê³¼ ë¦¬í¬íŠ¸ | 2026-02-17 |
| 6 | `6_ADDITIONAL_ANALYSES_PLAN.md` | ì¶”ê°€ 7ê°œ ë¶„ì„ ì‹¤í–‰ ê³„íš | 2026-02-17 |
| 7 | `7_PROGRESS_STATUS.md` | **í˜„ì¬ ë¬¸ì„œ** â€” ì „ì²´ ì§„í–‰ í˜„í™© | 2026-02-18 |
| â€” | `cci/CCI_ANALYSIS_REPORT.md` | CCI ì „ìš©: ê²°ê³¼, í•´ì„, ë¬¸ì œì , í–¥í›„ ê³„íš | 2026-02-18 |
